Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Genetics
Volume 2015, Article ID 301264, 5 pages
http://dx.doi.org/10.1155/2015/301264
Case Report

A Novel PHEX Mutation in Japanese Patients with X-Linked Hypophosphatemic Rickets

1Division of Endocrinology and Metabolism, Department of Internal Medicine, Niigata Rosai Hospital, Niigata 9428502, Japan
2Department of Clinical Laboratory, Niigata National Hospital, Niigata 9458585, Japan
3Department of Pharmacy, College of Pharmaceutical Sciences, Ritsumeikan University, Shiga 5258577, Japan
4Tokyo Women’s Medical University, Institute of Integrated Medical Sciences, Tokyo 1620054, Japan
5Department of Clinical Research, Saigata National Hospital, Niigata 9493193, Japan

Received 18 January 2015; Revised 28 February 2015; Accepted 5 March 2015

Academic Editor: Mohnish Suri

Copyright © 2015 Tetsuya Kawahara et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. M. Roetzer, F. Varga, E. Zwettler et al., “Novel PHEX mutation associated with hypophosphatemic rickets,” Nephron: Physiology, vol. 106, no. 1, pp. 8–12, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. R. V. Thakker and J. L. H. O'Riordan, “7 Inherited forms of rickets and osteomalacia,” Bailliere's Clinical Endocrinology and Metabolism, vol. 2, no. 1, pp. 157–191, 1988. View at Publisher · View at Google Scholar · View at Scopus
  3. P. S. N. Rowe, “The role of the PHEX gene (PEX) in families with X-linked hypophosphataemic rickets,” Current Opinion in Nephrology and Hypertension, vol. 7, no. 4, pp. 367–376, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Francis, S. Hennig, B. Korn et al., “A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets,” Nature Genetics, vol. 11, pp. 130–136, 1995. View at Publisher · View at Google Scholar
  5. K. B. Jonsson, R. Zahradnik, T. Larsson et al., “Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia,” The New England Journal of Medicine, vol. 348, no. 17, pp. 1656–1663, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Yamazaki, R. Okazaki, M. Shibata et al., “Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 11, pp. 4957–4960, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Liu, R. T. Premont, C. D. Kontos, J. Huang, and D. C. Rockey, “Endothelin-1 activates endothelial cell nitric-oxide synthase via heterotrimeric G-protein βγ subunit signaling to protein kinase B/Akt,” The Journal of Biological Chemistry, vol. 278, no. 50, pp. 49929–49935, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Liu, R. Guo, L. G. Simpson, Z.-S. Xiao, C. E. Burnham, and L. D. Quarles, “Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX,” The Journal of Biological Chemistry, vol. 278, no. 39, pp. 37419–37426, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. K. E. White, W. E. Evans, J. L. H. O'Riordan et al., “Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23,” Nature Genetics, vol. 26, no. 3, pp. 345–348, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Q. Feng, L. M. Ward, S. Liu et al., “Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism,” Nature Genetics, vol. 38, no. 11, pp. 1310–1315, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Lorenz-Depiereux, M. Bastepe, A. Benet-Pagès et al., “DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis,” Nature Genetics, vol. 38, no. 11, pp. 1248–1250, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Lorenz-Depiereux, D. Schnabel, D. Tiosano, G. Häusler, and T. M. Strom, “Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets,” American Journal of Human Genetics, vol. 86, no. 2, pp. 267–272, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Levy-Litan, E. Hershkovitz, L. Avizov et al., “Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene,” The American Journal of Human Genetics, vol. 86, no. 2, pp. 273–278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Larsson, X. Yu, S. I. Davis et al., “A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 4, pp. 2424–2427, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Goji, K. Ozaki, A. H. Sadewa, H. Nishio, and M. Matsuo, “Clinical case seminar: somatic and germline mosaicism for a mutation of the PHEX gene can lead to genetic transmission of X-linked hypophosphatemic rickets that mimics an autosomal dominant trait,” The Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 2, pp. 365–370, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Kumar, S. Henikoff, and P. C. Ng, “Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm,” Nature Protocols, vol. 4, no. 7, pp. 1073–1082, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. I. A. Adzhubei, S. Schmidt, L. Peshkin et al., “A method and server for predicting damaging missense mutations,” Nature Methods, vol. 7, no. 4, pp. 248–249, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Choi, G. E. Sims, S. Murphy, J. R. Miller, and A. P. Chan, “Predicting the functional effect of amino acid substitutions and indels,” PLoS ONE, vol. 7, no. 10, Article ID e46688, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Sabbagh, G. Boileau, M. Campos, A. K. Carmona, and H. S. Tenenhouse, “Structure and function of disease-causing missense mutations in the PHEX gene,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 5, pp. 2213–2222, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Sahay and R. Sahay, “Rickets-vitamin D deficiency and dependency,” Indian Journal of Endocrinology and Metabolism, vol. 16, pp. 164–176, 2012. View at Google Scholar
  21. T. O. Carpenter, E. A. Imel, I. A. Holm, S. M. Jan de Beur, and K. L. Insogna, “A clinician's guide to X-linked hypophosphatemia,” Journal of Bone and Mineral Research, vol. 26, no. 7, pp. 1381–1388, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. E. A. Imel, M. Peacock, P. Pitukcheewanont et al., “Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 6, pp. 2055–2061, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Endo, S. Fukumoto, K. Ozono et al., “Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement,” Bone, vol. 42, no. 6, pp. 1235–1239, 2008. View at Publisher · View at Google Scholar · View at Scopus